What is Nivolumab: Uses, Dosage, Side Effects and More

Nivolumab is a powerful cancer treatment medication that helps your immune system fight cancer cells more effectively. It's given through an IV in your arm at a cancer treatment center, and it works by removing the "brakes" that cancer cells put on your immune system.

This medication represents a breakthrough in cancer treatment called immunotherapy. Unlike traditional chemotherapy that directly attacks cancer cells, nivolumab teaches your own immune system to recognize and destroy cancer cells that were previously hiding from your body's natural defenses.

What is Nivolumab?

Nivolumab is a type of immunotherapy drug called a monoclonal antibody. Think of it as a specially designed key that unlocks your immune system's ability to fight cancer more effectively.

The medication works by blocking a protein called PD-1 on your immune cells. Cancer cells often use this protein to hide from your immune system, like putting on an invisibility cloak. When nivolumab blocks PD-1, it removes this cloak and allows your immune system to see and attack the cancer cells.

This treatment is part of a newer approach to cancer care that harnesses your body's natural fighting power. It's often used when other treatments haven't worked or in combination with other cancer therapies.

What is Nivolumab Used For?

Nivolumab treats several types of advanced cancers, particularly when they have spread or haven't responded to other treatments. Your oncologist will determine if this medication is right for your specific cancer type and situation.

The medication is commonly used for these cancer types, each requiring careful evaluation by your medical team:

• Melanoma (advanced skin cancer)
• Non-small cell lung cancer
• Kidney cancer (renal cell carcinoma)
• Hodgkin lymphoma
• Head and neck cancers
• Bladder cancer
• Liver cancer
• Colorectal cancer with specific genetic markers

Your doctor will also test your cancer for certain biomarkers to predict how well nivolumab might work for you. This personalized approach helps ensure you receive the most effective treatment possible.

How Does Nivolumab Work?

Nivolumab is considered a potent medication that works differently from traditional cancer treatments. Instead of directly killing cancer cells, it strengthens your immune system's natural ability to fight cancer.

Your immune system has built-in checkpoints that prevent it from attacking healthy cells. Cancer cells exploit these checkpoints by sending signals that say "don't attack me." Nivolumab blocks these deceptive signals, allowing your immune system to recognize cancer cells as threats.

This process can take time to show results, unlike chemotherapy which often works more quickly. Some patients see improvement within weeks, while others may need several months of treatment before noticing benefits. Your medical team will monitor your progress through regular scans and blood tests.

How Should I Take Nivolumab?

Nivolumab is given as an intravenous infusion at a cancer treatment center or hospital. You cannot take this medication at home, as it requires careful medical supervision during administration.

The infusion typically takes about 30 minutes to an hour. Your healthcare team will insert a small IV catheter into a vein in your arm or hand, similar to getting blood drawn. You'll sit comfortably in a reclining chair during the treatment.

Before each infusion, your medical team will check your vital signs and review how you're feeling. They may give you medications to prevent allergic reactions, such as antihistamines or steroids. You don't need to fast before treatment, and you can eat normally on infusion days.

The treatment schedule varies depending on your cancer type and overall treatment plan. Most patients receive nivolumab every two to four weeks, with each cycle carefully timed to maximize effectiveness while allowing your body to recover.

How Long Should I Take Nivolumab For?

The duration of nivolumab treatment varies significantly from person to person, depending on how your cancer responds and how well you tolerate the medication. Some patients continue treatment for several months, while others may need it for a year or longer.

Your oncologist will regularly assess your progress through imaging scans, blood tests, and physical examinations. If your cancer is responding well and you're tolerating the medication without serious side effects, treatment typically continues.

Treatment may be stopped if your cancer progresses despite the medication, if you develop serious side effects, or if your cancer goes into remission. Some patients can safely stop treatment after achieving a complete response, while others may need ongoing therapy to maintain their improvement.

Your medical team will work closely with you to determine the best treatment duration for your specific situation. They'll consider factors like your cancer type, overall health, treatment response, and personal preferences when making these decisions.

What Are the Side Effects of Nivolumab?

Nivolumab can cause side effects because it activates your immune system, which sometimes attacks healthy tissues along with cancer cells. Most side effects are manageable with proper medical care, and many patients tolerate this treatment well.

Understanding what to expect can help you recognize when to contact your healthcare team. Here are the most common side effects you might experience:

• Fatigue and feeling more tired than usual
• Skin rash or itching
• Diarrhea or changes in bowel movements
• Nausea or decreased appetite
• Cough or shortness of breath
• Joint or muscle pain
• Headache

These common side effects usually develop gradually and can often be managed with medications or lifestyle adjustments. Your medical team will provide specific guidance on managing each symptom.

Some patients may experience more serious side effects that require immediate medical attention. These immune-related side effects can affect various organs and need prompt treatment:

• Severe diarrhea or colitis (inflammation of the colon)
• Pneumonitis (lung inflammation)
• Hepatitis (liver inflammation)
• Thyroid problems
• Kidney inflammation
• Severe skin reactions
• Neurological problems

While these serious side effects are less common, they can be life-threatening if not treated promptly. Your healthcare team will monitor you carefully and teach you warning signs to watch for between treatments.

Who Should Not Take Nivolumab?

Nivolumab isn't suitable for everyone, and your oncologist will carefully evaluate whether this medication is safe for you. Certain medical conditions or circumstances may make this treatment too risky.

Your doctor will review your complete medical history before recommending nivolumab. They'll pay special attention to these important factors:

• Active autoimmune diseases like lupus or rheumatoid arthritis
• Previous organ transplant recipients
• Severe lung disease or breathing problems
• Active infections that your immune system is fighting
• Pregnancy or breastfeeding
• Severe liver disease
• History of severe allergic reactions to similar medications

Having one of these conditions doesn't automatically disqualify you from treatment, but it means your medical team will need to weigh the benefits against the risks more carefully. They may recommend additional monitoring or alternative treatments.

Your doctor will also consider your overall health status, other medications you're taking, and your ability to attend regular appointments for monitoring. Open communication about your health history helps ensure you receive the safest and most effective treatment possible.

Nivolumab Brand Name

Nivolumab is sold under the brand name Opdivo, manufactured by Bristol Myers Squibb. You may see both names used interchangeably in your medical records and treatment documentation.

When discussing your treatment with healthcare providers, insurance companies, or pharmacies, both "nivolumab" and "Opdivo" refer to the same medication. Your treatment center will handle ordering and preparing the medication for your infusions.

The medication comes in single-use vials that are specially prepared for each patient's dose. Your healthcare team calculates the exact amount you need based on your body weight and the specific treatment protocol for your cancer type.

Nivolumab Alternatives

Several other immunotherapy medications work similarly to nivolumab, and your oncologist may consider these alternatives depending on your specific cancer type and treatment history. Each option has unique benefits and considerations.

Other PD-1 inhibitors that work like nivolumab include pembrolizumab (Keytruda) and cemiplimab (Libtayo). These medications block the same pathway but may have different dosing schedules or approval for different cancer types.

Your doctor might also consider PD-L1 inhibitors like atezolizumab (Tecentriq), durvalumab (Imfinzi), or avelumab (Bavencio). These medications target a slightly different part of the same immune checkpoint pathway.

The choice between these alternatives depends on factors like your cancer type, previous treatments, test results showing how your cancer might respond, and your overall health. Your oncologist will explain why they recommend one option over another for your specific situation.

Is Nivolumab Better Than Pembrolizumab?

Nivolumab and pembrolizumab are both excellent immunotherapy options, but neither is universally better than the other. The best choice depends on your specific cancer type, biomarker results, and individual circumstances.

Both medications work by blocking PD-1 receptors, but they have different dosing schedules and may be approved for different cancer types. Pembrolizumab is often given every three to six weeks, while nivolumab is typically given every two to four weeks.

Research shows that both medications can be highly effective for appropriate patients. Some studies suggest one might work better for certain cancer types or in specific situations, but head-to-head comparisons are limited.

Your oncologist will consider factors like your cancer's biomarker profile, your treatment history, and practical considerations like dosing schedule when choosing between these options. The goal is finding the medication most likely to help you while minimizing side effects.